Aside from this, it was shown that NR1D1 improved the susceptibility of breast cancer cells to DNA damage-induced chemotherapy, hence increasing the likelihood of PCR in breast cancer patients [29]. The gene discussed is NR1D1; the disease is breast carcinoma.